10 principais nektar.com concorrentes

biomarin.com

Our employees include some of the most talented professionals in the biopharma industry. Learn more about career opportunities at BioMarin and explore openings to join our team.

nervgen.com

Investor FAQ Most frequently asked questions and answers Where is NervGen’s stock listed? NervGen trades in Canada on the TSX.V under the symbol NGEN and in the U.S. on the OTCQB under the symbol NGENF. How many NervGen shares are issued and outstanding? Refer to NervGen’s latest filed financial statements for the latest available share […]

tubulis.com

MUNICH, GERMANY, March 03, 2023 – We are very proud we made it on the cover of the latest issue of the Royal Society of Chemistry’s flagship journal Chemical Science! Our joint publication with Christian P.R. Hackenberger highlights the ability of our novel ADC conjugation technology P5 to create ADCs with a high drug-to-antibody-ratio (DAR) […]

xenon-pharma.com

A leading neuroscience company advancing therapeutic approach to neurological and psychiatric disorders.

apogeetherapeutics.com

Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immune (I&I) diseases with high unmet need

ascendispharma.com

We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, caregivers & HCPs.

plustherapeutics.com

REYOBIQ is a precise radiotherapeutic targeting primary and metastatic central nervous system cancers in adults and children.

newdrugapprovals.org

2010-2020 PATENT EXPIRY DATES 1/3 The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs a…

dementiasplatform.uk

dementias platform uk is a high quality research environment. we make the translation from discoveries to therapeutics easier, better and faster.

imm.ox.ac.uk

the mrc weatherall institute of molecular medicine at the university of oxford was founded in 1989 by sir david weatherall to foster research in molecular and cell biology, with the aim of improving human health. through our excellent basic and applied research we have become leaders in translational medicine. our research has resulted in improved understanding, diagnosis and treatment of a wide range of human diseases.